BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Yehia BR, Blumberg EA. Mycobacterium tuberculosis infection in liver transplantation. Liver Transpl 2010;16:1129-35. [PMID: 20879011 DOI: 10.1002/lt.22133] [Cited by in Crossref: 40] [Cited by in F6Publishing: 36] [Article Influence: 3.1] [Reference Citation Analysis]
Number Citing Articles
1 Green M, Hanisch B, Michaels MG. Infections in Solid Organ Transplant Recipients. Principles and Practice of Pediatric Infectious Diseases 2023. [DOI: 10.1016/b978-0-323-75608-2.00095-1] [Reference Citation Analysis]
2 Yang Y, Wang H, Hu W, Bai G, Hua C. Diagnostic Value of Interferon-Gamma Release Assays for Tuberculosis in the Immunocompromised Population. Diagnostics 2022;12:453. [DOI: 10.3390/diagnostics12020453] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Lauar ID, Faria LC, Romanelli RMC, Clemente WT. Latent tuberculosis: Risk factors, screening and treatment in liver transplantation recipients from an endemic area. World J Transplant 2021; 11(12): 512-522 [DOI: 10.5500/wjt.v11.i12.512] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
4 Dubois M, Dixit A, Lamb G. Tuberculosis in Pediatric Solid Organ and Hematopoietic Stem Cell Recipients. Glob Pediatr Health 2021;8:2333794X20981548. [PMID: 33506075 DOI: 10.1177/2333794X20981548] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
5 Wang Y, Salvador NG, Lin C, Wu C, Lin T, Lee W, Chan Y, Chen C, Co JS, Encarnacion DD. Comparative analysis of the drug-drug interaction between immunosuppressants, safety and efficacy of rifabutin from rifampicin-based Anti-TB treatment in living donor liver transplant recipients with active tuberculosis. Biomedical Journal 2020. [DOI: 10.1016/j.bj.2020.08.010] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
6 Godfrey MS, Friedman LN. Tuberculosis and Biologic Therapies: Anti-Tumor Necrosis Factor-α and Beyond. Clin Chest Med 2019;40:721-39. [PMID: 31731980 DOI: 10.1016/j.ccm.2019.07.003] [Cited by in Crossref: 20] [Cited by in F6Publishing: 24] [Article Influence: 6.7] [Reference Citation Analysis]
7 Leong LY, Lin PC, Chi CY, Chou CH, Lu MC, Liao WC, Ho MW, Wang JH, Jeng LB. Risk factors of tuberculosis after liver transplant in a tertiary care hospital. J Microbiol Immunol Infect 2021;54:312-8. [PMID: 31668794 DOI: 10.1016/j.jmii.2019.08.006] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
8 Di Dato F, Nunziata F, Rosa M, Iorio R, Spagnuolo MI. Tubercular hemoptysis in a young liver transplanted patient: Case report. Medicine (Baltimore) 2019;98:e16761. [PMID: 31415374 DOI: 10.1097/MD.0000000000016761] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
9 Silva JT, San-Juan R, Fernández-Ruiz M, Aguado JM. Fluoroquinolones for the treatment of latent Mycobacterium tuberculosis infection in liver transplantation. World J Gastroenterol 2019; 25(26): 3291-3298 [PMID: 31341356 DOI: 10.3748/wjg.v25.i26.3291] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
10 Salvador NGA, Wee SY, Lin CC, Wu CC, Lu HI, Lin TL, Lee WF, Chan YC, Lin LM, Chen CL. Clinical Outcomes of Tuberculosis in Recipients After Living Donor Liver Transplantation. Ann Transplant 2018;23:733-43. [PMID: 30337516 DOI: 10.12659/AOT.911034] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
11 Qiu J, Liu S, Wang Q. Treatment of tuberculosis infection complicated with liver transplant. Infection International 2018;7:81-7. [DOI: 10.2478/ii-2018-0025] [Reference Citation Analysis]
12 Jung BH, Park JI, Lee SG. Urgent Living-Donor Liver Transplantation in a Patient With Concurrent Active Tuberculosis: A Case Report. Transplant Proc. 2018;50:910-914. [PMID: 29661461 DOI: 10.1016/j.transproceed.2018.02.013] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
13 Schuhmacher Neto R, Giacomelli I, Schuller Nin C, da Silva Moreira J, Comaru Pasqualotto A, Marchiori E, Loureiro Irion K, Hochhegger B. High-resolution CT findings of pulmonary tuberculosis in liver transplant patients. Clinical Radiology 2017;72:899.e9-899.e14. [DOI: 10.1016/j.crad.2017.05.006] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
14 Dorsett M, Liang SY. Diagnosis and Treatment of Central Nervous System Infections in the Emergency Department. Emerg Med Clin North Am 2016;34:917-42. [PMID: 27741995 DOI: 10.1016/j.emc.2016.06.013] [Cited by in Crossref: 38] [Cited by in F6Publishing: 49] [Article Influence: 6.3] [Reference Citation Analysis]
15 European Association for the Study of the Liver. Electronic address: easloffice@easloffice.eu. EASL Clinical Practice Guidelines: Liver transplantation. J Hepatol 2016;64:433-85. [PMID: 26597456 DOI: 10.1016/j.jhep.2015.10.006] [Cited by in Crossref: 521] [Cited by in F6Publishing: 528] [Article Influence: 74.4] [Reference Citation Analysis]
16 Mah A, Wright A. Infectious Considerations in the Pre-Transplant Evaluation of Cirrhotic Patients Awaiting Orthotopic Liver Transplantation. Curr Infect Dis Rep. 2016;18:4. [PMID: 26743200 DOI: 10.1007/s11908-015-0514-5] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
17 Lee I, Blumberg EA. Risk and Epidemiology of Infections After Solid Organ Transplantation. Transplant Infections 2016. [DOI: 10.1007/978-3-319-28797-3_7] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
18 Meije Y, Piersimoni C, Torre-Cisneros J, Dilektasli AG, Aguado JM; ESCMID Study Group of Infection in Compromised Hosts. Mycobacterial infections in solid organ transplant recipients. Clin Microbiol Infect. 2014;20 Suppl 7:89-101. [PMID: 24707957 DOI: 10.1111/1469-0691.12641] [Cited by in Crossref: 72] [Cited by in F6Publishing: 77] [Article Influence: 9.0] [Reference Citation Analysis]
19 Chen CY, Liu CJ, Feng JY, Loong CC, Liu C, Hsia CY, Hu LY, Lin NC, Hu YW, Yeh CM, Chen TJ, Yang CC. Incidence and Risk Factors for Tuberculosis After Liver Transplantation in an Endemic Area: A Nationwide Population-Based Matched Cohort Study. Am J Transplant 2015;15:2180-7. [PMID: 25872600 DOI: 10.1111/ajt.13235] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 2.8] [Reference Citation Analysis]
20 Holt CD, Winston DJ. Infections After Transplantation. Transplantation of the Liver 2015. [DOI: 10.1016/b978-1-4557-0268-8.00078-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
21 Sun H. Treating tuberculosis in solid organ transplant recipients. Current Opinion in Infectious Diseases 2014;27:501-5. [DOI: 10.1097/qco.0000000000000102] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.2] [Reference Citation Analysis]
22 Fagiuoli S, Colli A, Bruno R, Craxì A, Gaeta GB, Grossi P, Mondelli MU, Puoti M, Sagnelli E, Stefani S, Toniutto P, Burra P; 2011 AISF Single Topic Group. Management of infections pre- and post-liver transplantation: report of an AISF consensus conference. J Hepatol 2014;60:1075-89. [PMID: 24384327 DOI: 10.1016/j.jhep.2013.12.021] [Cited by in Crossref: 57] [Cited by in F6Publishing: 58] [Article Influence: 6.3] [Reference Citation Analysis]
23 Camus C. Complications infectieuses chez le transplanté hépatique. Réanimation 2014;23:317-326. [DOI: 10.1007/s13546-014-0888-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
24 Stine JG, Lewis JH. Hepatotoxicity of antibiotics: a review and update for the clinician. Clin Liver Dis 2013;17:609-42, ix. [PMID: 24099021 DOI: 10.1016/j.cld.2013.07.008] [Cited by in Crossref: 30] [Cited by in F6Publishing: 29] [Article Influence: 3.0] [Reference Citation Analysis]
25 Geramizadeh B, Nikeghbalian S, Janghorban P, Malekhosseini SA. Isolated tuberculosis of transplanted liver, a case report and review of the literature. Hepat Mon 2013;13:e6691. [PMID: 23914226 DOI: 10.5812/hepatmon.6691] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
26 Subramanian AK, Morris MI; AST Infectious Diseases Community of Practice. Mycobacterium tuberculosis infections in solid organ transplantation. Am J Transplant 2013;13 Suppl 4:68-76. [PMID: 23465000 DOI: 10.1111/ajt.12100] [Cited by in Crossref: 129] [Cited by in F6Publishing: 133] [Article Influence: 12.9] [Reference Citation Analysis]
27 Verma S, Kaplowitz N. Hepatotoxicity of Antitubercular Drugs. Drug-Induced Liver Disease. Elsevier; 2013. pp. 483-504. [DOI: 10.1016/b978-0-12-387817-5.00027-3] [Cited by in Crossref: 4] [Article Influence: 0.4] [Reference Citation Analysis]
28 Lucey MR, Terrault N, Ojo L, Hay JE, Neuberger J, Blumberg E, Teperman LW. Long-term management of the successful adult liver transplant: 2012 practice guideline by the American Association for the Study of Liver Diseases and the American Society of Transplantation. Liver Transpl 2013;19:3-26. [PMID: 23281277 DOI: 10.1002/lt.23566] [Cited by in Crossref: 321] [Cited by in F6Publishing: 274] [Article Influence: 32.1] [Reference Citation Analysis]
29 Schneider F, Guillot M, Chomette M, Douiri N, Herbrecht J, Diouf M, Kremer S, Lavigne T, Lutun P. Prise en charge des infections chez les adultes transplantés d’organe(s). Références en réanimation. Collection de la SRLF 2013. [DOI: 10.1007/978-2-8178-0389-0_28] [Reference Citation Analysis]
30 Lefeuvre S, Rebaudet S, Billaud EM, Wyplosz B. Management of rifamycins-everolimus drug-drug interactions in a liver-transplant patient with pulmonary tuberculosis. Transpl Int. 2012;25:e120-e123. [PMID: 22994607 DOI: 10.1111/j.1432-2277.2012.01561.x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 1.5] [Reference Citation Analysis]
31 Ha Y, Joo E, Park S, Wi Y, Kang C, Chung D, Joh J, Lee S, Song J, Peck K. Tacrolimus as a risk factor for tuberculosis and outcome of treatment with rifampicin in solid organ transplant recipients. Transpl Infect Dis 2012;14:626-34. [DOI: 10.1111/j.1399-3062.2012.00721.x] [Cited by in Crossref: 28] [Cited by in F6Publishing: 29] [Article Influence: 2.5] [Reference Citation Analysis]
32 Spoerl D, Bircher AJ. Drugs that act on the immune system: cytokines and monoclonal antibodies. A worldwide yearly survey of new data in adverse drug reactions and interactions 2012. [DOI: 10.1016/b978-0-444-59499-0.00037-4] [Reference Citation Analysis]
33 Schreiber HA, Harding JS, Hunt O, Altamirano CJ, Hulseberg PD, Stewart D, Fabry Z, Sandor M. Inflammatory dendritic cells migrate in and out of transplanted chronic mycobacterial granulomas in mice. J Clin Invest 2011;121:3902-13. [PMID: 21911937 DOI: 10.1172/JCI45113] [Cited by in Crossref: 42] [Cited by in F6Publishing: 46] [Article Influence: 3.5] [Reference Citation Analysis]
34 Viñuela EF, Mirza DF. Preparation of the patient for liver transplantation. Indian Journal of Transplantation 2011;5:120-125. [DOI: 10.1016/s2212-0017(11)60001-4] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
35 Agoglia L, Balbi E, Halpern M, Roma J, Carius L, Martinho J, Moreira L. Tuberculosis in Liver Transplant Recipients: Prophylaxis in an Endemic Area. Transplantation Proceedings 2011;43:199-202. [DOI: 10.1016/j.transproceed.2010.12.033] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.2] [Reference Citation Analysis]
36 Donataccio D, Bravo PD, Masotto A, Ceola M, Calabrò F, Donataccio M. Liver Transplantation in a Monolung Patient: A Strategy of Sequential Treatments of Multiple Lung Tuberculosis Ca-vitations and Hepatocellular Carcinoma on Hepatitis B Related Virus Cirrhosis. SS 2011;02:257-261. [DOI: 10.4236/ss.2011.25057] [Reference Citation Analysis]